glp 1 metabolism Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation GLP-1 receptor agonists and myocardial
Description
Tirzepatide produced greater A1c reductions in the SURPASS-2 head-to-head trial, making it the stronger option for glucose control
Unlike Ozempic and Wegovy, Mounjaro works as both a GLP-1 and GIP agonist
It's important to note that while these medications are licensed for weight management, NHS access follows specific NICE appraisals which are typically narrower than the licensed indications and usually require treatment within specialist weight management services
Legitimate medical care always involves a prescriber-patient relationship
